Estra-1,3,5(10),16-tetraen-3-ol benzoate



Compound IDCDAMM00152
Common nameEstra-1,3,5(10),16-tetraen-3-ol benzoate
IUPAC name[(8S,9S,13R,14S)-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-yl] benzoate
Molecular formulaC25H26O2

Experimental data

Retention time43.68
Adduct[M+H]+
Actual mz359.2
Theoretical mz359.201
Error2.64
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score4.5128

Identifiers and class information

Inchi keyKHAIFVOAJPIDQL-AHCIIZGASA-N
SmilesCC12CCC3C(C1CC=C2)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)2
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)358.479
Computed dipole moment(dipole)2.224
Total solvent accessible surface area (SASA)677.719
Hydrophobic component of SASA (FOSA)258.734
Hydrophilic component of SASA (FISA)39.098
Pie component of the SASA (PISA)379.887
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1203.57
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)2.5
Free energy of solvation of dipole (dip^2/V)0.0041113
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.807414
Predicted polarizability in cubic angstroms (QPpolrz)44.357
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.366
Predicted octanol/gas partition coefficient (QPlogPoct)15.899
Predicted water/gas partition coefficient (QPlogPw)6.222
Predicted octanol/water partition coefficient (QPlogPo/w)6.104
Predicted aqueous solubility (QPlogS)-7.425
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.322
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.46
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4218.24
Predicted brain/blood partition coefficient (QPlogBB)0.043
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2344.46
Predicted skin permeability, log Kp (QPlogKp)-0.71
PM3 calculated ionization potential (IP(ev))9.265
PM3 calculated electron affinity (EA(eV))0.469
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)1.358
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)35.042
Number of nitrogen and oxygen atoms (#NandO)2
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P42330AKR1C3Aldo-keto-reductase family 1 member C3T60857SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P08185SERPINA6Corticosteroid binding globulinT88452SEA
P11511CYP19A1Cytochrome P450 19A1T13260SEA
Q07869PPARAPeroxisome proliferator-activated receptor alphaT86591SEA
Q03181PPARDPeroxisome proliferator-activated receptor deltaT36557SEA
P03372ESR1Estrogen receptor alphaT02506SEA
P33527ABCC1Multidrug resistance-associated protein 1T11288SEA
O95718ESRRBEstrogen-related receptor betaT42025SEA
P08842STSSteryl-sulfataseT33489SEA
Q14330GPR18N-arachidonyl glycine receptorT72267SEA
Q9Y6L6SLCO1B1Solute carrier organic anion transporter family member 1B1T46814SEA
Q99527GPER1G-protein coupled estrogen receptor 1T65236SEA
P10323ACRAcrosinT24595SEA
O75751EMTHOrganic cation transporter 3T55948SEA
O15439ABCC4Multidrug resistance protein 4T39919SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T60857DI0145Female pelvic pain[ICD-11: GA34]P42330AKR1C3
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T88452DI0037Asthma[ICD-11: CA23]P08185SERPINA6
T88452DI0339Postoperative inflammation[ICD-11: 1A00-CA43]P08185SERPINA6
T88452DI0362Respiratory system disease[ICD-11: CB40-CB7Z]P08185SERPINA6
T13260DI0062Breast cancer[ICD-11: 2C60-2C6Y]P11511CYP19A1
T13260DI0108Cushing syndrome[ICD-11: 5A70]P11511CYP19A1
T86591DI0187Hyperlipidemia[ICD-11: 5C80]Q07869PPARA
T86591DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]Q07869PPARA
T86591DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q07869PPARA
T36557DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]Q03181PPARD
T36557DI0308Obesity[ICD-11: 5B80-5B81]Q03181PPARD
T02506DI0106COVID-19[ICD-11: 1D6Y]P03372ESR1
T11288DI0167Gout[ICD-11: FA25]P33527ABCC1
T33489DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]P08842STS
T65236DI0100Contraceptive management[ICD-11: QA21]Q99527GPER1

Copyright © 2025